 |
International Conference and Exhibition on
Biowaivers & Biosimilars
September 10-12, 2012 in Hilton San Antonio Airport, USA
|
|
|
|
|
|
|
|
|
|
|
|
Biosimilars-2012 Report
The International Conference and Exhibition on Biowaivers & Biosimilars, hosted by the OMICS Group was held during September 10-12, 2012 at Hilton San Antonio Airport, USA. Generous response and active participation were received from the Editorial Board Members of OMICS Group Journals as well as from scientists, researchers and leaders from pharma, government organizations, students who made this conference as one of the most successful and productive events in 2012 from OMICS Group.
The conference was carried out through various sessions, in which discussions were held on the following scientific tracks:
- Biosimilars: Innovator Pharmaceutical Products
- Biosimilars: Regulatory Approach
- Skill Set for Biosimilars Development
- Clinical Studies
- Biosimilars Therapeutics
- Commercialization or Globalization of Biosimilars
- Plant Produced Biosimilar Products
- Aggregation and Immunogenicity of Biosimilars
- BCS & IVIVC Based Biowaivers
- Analytical Strategies
The response to the International Conference and Exhibition on Biowaivers & Biosimilars was huge and was attended by about less than 200 delegates representing 30 countries from different corners of the world.
The conference was initiated with a series of invited lectures delivered by both Honorable guests and members of the Keynote forum. The list included Carmine Lanni Bioanalytical Development Services, USA; Brian Dorn, Barnes & Thornburg LLP, USA; Laszlo Endrenyi, University of Toronto, Canada; David Goodall, Paraytec Limited, UK; Indu S. Javeri, CuriRx Inc., USA; Lisa J. Murray, Absorption Systems, USA; Paul A. Calvo, Sterne, Kessler, Goldstein & Fox P.L.L.C., USA; Michael McLean, PlantForm Corporation, Canada.
All the above mentioned Honorable guests and Keynote speakers gave their energetic and fruitful contributions at Biosimilars-2012.
All accepted abstracts have been indexed in OMICS Group Journal of Bioequivalence & Bioavailability as a special issue. The theme of this conference was on "A Synergistic Approach towards Biowaivers & Biosimilars". Based on this, speaker's discussions included many recommendations.
We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Biosimilars-2012, and with their unique feedback, OMICS Group would like to announce the "2nd International Conference and Exhibition on Biowaivers & Biosimilars" to be held at Hilton, Raleigh-NC, USA during September 23-25, 2013.
|
|
Expert Presentations
|
|
|
|
|
|
Conference Secretariat: Biosimilars-2012, OMICS Group Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: +1-650-268-9744, Fax: +1-650-618-1414
|
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
|
|
|
Operated by: Editors - Journal of Bioanalysis and Biomedicine, Journal of Bioequivalence and Bioavailability and Pharmaceutica Analytica Acta |
The Organizers reserve the rights to make changes and adjustment to the information in this website
© Copyright 2008-2012 OMICS Group - All rights reserved |
|
|
|
|
RSS
Facebook
LinkedIn
Twitter
Blog